Patents by Inventor Devin QUINLAN

Devin QUINLAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES THAT BIND EBOLA GLYCOPROTEIN AND USES THEREOF
    Publication number: 20210095007
    Abstract: Isolated monoclonal antibodies which bind to Ebola virus glycoprotein and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
    Type: Application
    Filed: December 4, 2020
    Publication date: April 1, 2021
    Inventors: Ram SASISEKHARAN, Kannan THARAKARAMAN, Devin QUINLAN, Vidya SUBRAMANIAN
  • Antibodies that bind Ebola glycoprotein and uses thereof
    Patent number: 10894818
    Abstract: Isolated monoclonal antibodies which bind to Ebola virus glycoprotein and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: January 19, 2021
    Assignee: Massachusetts Institute of Technology
    Inventors: Ram Sasisekharan, Kannan Tharakaraman, Devin Quinlan, Vidya Subramanian
  • ANTIBODIES THAT BIND EBOLA GLYCOPROTEIN AND USES THEREOF
    Publication number: 20170298120
    Abstract: Isolated monoclonal antibodies which bind to Ebola virus glycoprotein and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
    Type: Application
    Filed: October 2, 2015
    Publication date: October 19, 2017
    Applicant: Massachusetts Institute of Technology
    Inventors: Ram SASISEKHARAN, Kannan THARAKARAMAN, Devin QUINLAN, Vidya SUBRAMANIAN